Early results with the new Clareon and Clareon toric intraocular lens

Ben R. LaHood

Meeting:  2022 RANZCO


Date:      -

Session Title: CATARACT

Session Time:      -

Purpose: To assess real life results of implanting the new Clareon aspheric monofocal and Clareon toric intraocular lens (IOL) in terms of visual outcomes, refractive predictability, rates of posterior capsule opacification and glistenings.

Methods: Twenty-two eyes of 14 patients underwent uncomplicated cataract surgery with implantation of Clareon non-toric (8) and Clareon toric (12) IOLs via a
2.2 mm wound assisted implantation technique. Eyes were assessed one day, one week, one month and three months post-operatively. Subjective refraction was performed at one month. Slit-lamp examination and dilated red-reflex photography was performed to assess for glistenings and posterior capsule opacification. Two eyes were excluded from refractive and visual assessment due to macula pathologies.

Results: No complications occurred in any surgery. Residual refractive error was within 0.5D in 95% of cases and within 0.75D in 100% of cases. Astigmatic mean absolute prediction error was 0.22D. Unaided distance visual acuity in distance targeted eyes was 6/6 or better in 93.75% of cases. One eye underwent YAG posterior capsulotomy due to posterior capsule opacification at one month. No glistenings were seen clinically or photo graphically during all follow-up.

Conclusion: The newly released Clareon toric and Clareon non-toric IOLs function extremely well in a real life patient population. They show excellent refractive predictability with a very low rate of posterior capsule opacity and no glistenings.